Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development DayBusiness Wire • 9 days ago
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline...
Share to Feed
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated and metabolic diseases, today...
Aldeyra Therapeutics, Inc (NASDAQ:ALDX - Get Free Report) major shareholder Perceptive Advisors Llc purchased 8,374 shares of the business's stock in a transaction dated Monday, April 1st. The stock...
Aldeyra Therapeutics, Inc (NASDAQ:ALDX - Get Free Report) major shareholder Perceptive Advisors Llc purchased 309,847 shares of the stock in a transaction that occurred on Wednesday, April 3rd. The...
Aldeyra Therapeutics (NASDAQ:ALDX - Get Free Report)s stock had its "buy" rating restated by analysts at HC Wainwright in a research report issued to clients and investors on Tuesday...
Investors considering a purchase of Aldeyra Therapeutics Inc (ALDX) stock, but cautious about paying the going market price of 3.42/share, might benefit from considering selling puts among the...
This is a Bullish indicator signaling ALDX's price could rise from here. Traders may explore going long the stock or buying call options...
This is a signal that ALDX's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This price move could be a signal that ALDX may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today...